Skip to main content
. 2019 Dec 8;182(6):1369–1378. doi: 10.1111/bjd.18552

Figure 4.

Figure 4

Kaplan–Meier plots of duration of response per central review in patients receiving sonidegib 200 mg daily (responders only). BCC, basal cell carcinoma; laBCC, locally advanced BCC; mBCC, metastatic BCC; mo, months.